A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Josamycin EP Impurity E | Josamycin EP Impurity E. Uses: For analytical and research use. CAS No. 40615-47-2. Molecular formula: C43H71NO15. Mole weight: 842.03. Catalog: APB40615472. |  |
| Josamycin EP Impurity F | Josamycin EP Impurity F. Uses: For analytical and research use. Molecular formula: C35H59NO13. Mole weight: 701.85. Catalog: APB10552. | |
| Josamycin EP Impurity G | Josamycin EP Impurity G. Uses: For analytical and research use. Molecular formula: C37H61NO14. Mole weight: 743.89. Catalog: APB10553. | |
| Josamycin EP Impurity H | Josamycin EP Impurity H. Uses: For analytical and research use. Molecular formula: C40H67NO14. Mole weight: 785.97. Catalog: APB10555. | |
| Josamycin EP Impurity I | Josamycin EP Impurity I. Uses: For analytical and research use. Molecular formula: C38H63NO14. Mole weight: 757.92. Catalog: APB10554. | |
| Josamycin EP Impurity J | Josamycin EP Impurity J. Uses: For analytical and research use. Molecular formula: C43H71NO15. Mole weight: 842.03. Catalog: APB10556. | |
| Josamycin EP Impurity K | Josamycin EP Impurity K. Uses: For analytical and research use. Molecular formula: C40H65NO15. Mole weight: 799.95. Catalog: APB10557. | |
| Josamycin hydrochloride | Josamycin hydrochloride. Alternative Names: Josamycin HCl. CAS No. 11033-19-5. Purity: 98%. Product ID: ACM11033195. Molecular formula: C42H70ClNO15. Mole weight: 864.46. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Josiphos SL-J216-2 | Josiphos SL-J216-2 is a chiral phosphine ligand for enantioselective synthesis with high yield and high enantioselective results. Alternative Names: (S)-1-{(RP)-2-[Di(1-naphthyl)phosphino]ferrocenyl}ethyldi-tert-butylphosphine; (2S)-1-[(1S)-1-[Bis(1,1-dimethylethyl)phosphino]ethyl]-2-(di-1-naphthalenylphosphino)ferrocene. Grades: cp95%, ee99%. CAS No. 849924-44-3. Molecular formula: C40H44FeP2. Mole weight: 642.57. |  |
| JP104 | JP104, a aryl carbamate, is an irreversible FAAH inhibitor with a pIC50 of ~8[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 887264-45-1. Pack Sizes: 5 mg. Product ID: HY-121558. |  |
| JP-11646 | JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 (IC50 = 0.5 nM). JP11646 is freely reversible and ATP non-competitive. JP-11646 results in a decrease of PIM1, 2, and 3 mRNA. JP-11646 can effectively inhibit cell viability in small cell lung cancer (SCLC) and large cell neuroendocrine carcinomas of the lung (LCNEC). JP-11646 can cause a decrease in p-4EBP-1 protein, increasing the cleavage of caspases while decreasing caspase-3. JP-11646 induces apoptosis or necroptosis in cells. JP-11646 leads to reductions in MYC paralogs. JP-11646 can be used for the study of SCLC, LCNEC, human acute leukemia (AML), multiple myeloma (MM), and triple-negative breast cancer (TNBC)[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1902983-63-4. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-115590. | |
| JP 1302 dihydrochloride | JP 1302 dihydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 1259314-65-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| JP1302 dihydrochloride | JP1302 dihydrochloride is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 dihydrochloride shows antidepressant and antipsychotic-like effects. JP1302 dihydrochloride can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1259314-65-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103213. | |
| JP-153 | JP-153 is the Src-FAK-Paxillin signaling inhibitor. JP-153 inhibits Src-dependent phosphorylation of paxillin (Y118) and downstream activation of Akt (S473). JP-153 reduces VEGF-induced migration and proliferation in retinal endothelial cells. JP-153 can be uesd for the study of neovascular eye disease[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1802937-26-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-120417. | |
| JP-163-16 | JP-163-16 is a RelA/p65 PROTAC degrader. JP-163-16 selectively reduces the expression of RelA/p65 in a proteasome-dependent manner in cells. JP-163-16 can induce cell apoptosis by inhibiting the NF-κB signaling pathway. JP-163-16 can be used for research on RelA/p65-dependent tumours, such as chronic lymphocytic leukaemia (CLL). (Pink: RelA/p65 Ligand (HY-174865); Blue: CRBN Ligand (HY-A0003); Black: Linker; CRBN Ligand+Linker (HY-160241))[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3100147-70-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-174864. | |
| JPC0323 | JPC0323 is a dual 5-HT2C/5-HT2A receptor positive allosteric modulator. JPC0323 has on-target properties, acceptable plasma exposure and brain penetration. JPC0323 can be used for the research of neurological disease[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 5972-45-2. Pack Sizes: 1 mg. Product ID: HY-155672. | |
| JPE-1375 | JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 μM) and reduces TNF levels (EC50=4.5 μM) in mice. JPE-1375 can be used in studies of autoimmune and inflammatory diseases[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1254036-23-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148141. | |
| JPH203 | JPH203 Inhibitor. Uses: Scientific use. Product Category: TQ0081. CAS No. 1037592-40-7. |  |
| JPH203 | JPH203 is a potent and selective L-type amino acid transporter 1 (LAT1) inhibitor. It inhibits 14C-leucine uptake and cell growth in human colon cancer-derived HT-29 cells in vitro. It also inhibits 14C-leucine uptake in mouse renal proximal tubule cells expressing l-type amino acid transporter 1, and inhibits cell growth. It completely inhibits the proliferation of YD-38 cells in a dose- and time-dependent manner. It suppresses proliferation in cancer cell lines and is used for cancer research. It was developed by J-Pharma and in clinic phase 1 trials. Uses: Jph203 suppresses proliferation in cancer cell lines and is used for cancer research. Alternative Names: KYT-0353;KYT0353;JPH-203; KYT 0353;JPH 203;(S)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid. Grades: >98 %. CAS No. 1037592-40-7. Molecular formula: C23H19Cl2N3O. Mole weight: 472.32. | |
| JPH203 (Nanvuranlat) | Nanvuranlat (JPH203, KYT-0353), a selective L-type amino acid transporter 1 inhibitor, shows a dramatic inhibition of leucine uptake (IC50=0.06 μM) and cell growth (IC50=4.1 μM) in human colon cancer cells (HT-29), human oral cancer cells (YD-38) and leukemic cells. Group: Inhibitors. Alternative Names: KYT-0353. CAS No. 1037592-40-7. Pack Sizes: 5mg. Product ID: S8667. Formula: C23H19Cl2N3O4. Smiles: C1=CC=C(C=C1)C2=NC3=CC(=CC(=C3O2)COC4=C(C=C(C=C4Cl)CC(C(=O)O)N)Cl)N. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| JPM-OEt | JPM-OEt is a broad spectrum cysteine cathepsin inhibitor. JPM-OEt binds covalently in the active site, and irreversibly inhibits the cysteine cathepsin family. Antitumor activity[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 262381-84-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-102087. | |
| JPS036 | JPS036 is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC). JPS036 degrades class I histone deacetylase (HDAC). JPS036 is potent HDAC1/2 degrader correlated with greater total differentially expressed genes and enhanced apoptosis in HCT116 cells[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2669785-85-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg. Product ID: HY-145819. | |
| JQ1 | JQ1 Inhibitor. Uses: Scientific use. Product Category: T2110. CAS No. 1268524-70-4. | |
| JQ-1-Azidopropylamine | JQ-1-Azidopropylamine is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for BRD4 (HY-78695) and a PROTAC linker (HY-151862), which recruits E3 ligases. JQ-1-Azidopropylamine can be used for synthesis of PROTAC JY-21 (HY-174975)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2915642-70-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-174995. | |
| JQ-1 carboxylic acid | JQ-1 carboxylic acid, a (+)-JQ-1 (HY-13030) derivative, is a potent BET bromodomain inhibitor. JQ-1 carboxylic acid can be used to synthesize PROTAC, which can target the degradation of BRD4. Uses: Scientific research. Category: Signaling pathways. CAS No. 202592-23-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-78695. | |
| JQ-1 carboxylic acid-PEG3-C2-NH2 | JQ-1 carboxylic acid-PEG3-C2-NH2 is a E3 ligase ligand-linker conjugate that can be used in the synthesis of PROTACT[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2098790-24-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-169150. | |
| JQAD1 | JQAD1 is a CRBN-dependent PROTAC that selectively targets EP300 for degradation. JQAD1 suppresses EP300 expression and the H3K27ac modification. JQAD1 induces apoptosis. JQAD1 can be used in research of cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2417097-18-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145765. | |
| JQKD82 | JQKD82 is a selective and cell-permeable KDM5 inhibitor that increases H3K4me3 and can be used in multiple myeloma studies. Alternative Names: JADA82; PCK82; 4-Pyridinecarboxylic acid, 2-[[[2-[[2-(dimethylamino)ethyl]ethylamino]-2-oxoethyl]amino]methyl]-, 2,4-bis(1-methylethoxy)phenyl ester; 2,4-diisopropoxyphenyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate. Grades: ≥95%. CAS No. 2410512-38-6. Molecular formula: C27H40N4O5. Mole weight: 500.63. | |
| JQKD82 trihydrochloride | JQKD82 (JADA82) trihydrochloride is a cell-permeable and selective KDM5 inhibitor. JQKD82 trihydrochloride increases H3K4me3 and can be used for the research of multiple myeloma[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: JADA82 trihydrochloride; PCK82 trihydrochloride. CAS No. 2863676-87-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-138691A. | |
| JR14a | JR14a is a potent thiophene antagonist of human complement C3a receptor. JR14a shows selectivity for the human C3a receptor over C5a receptor. JR14a can suppress C3aR-mediated inflammation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2411440-41-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 1 g. Product ID: HY-138161. | |
| JR-AB2-011 | JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM)[1].JR-AB2-011 decreases the phosphorylation level of Akt, decreases MMP2 activity, thereby reducing the ability of tumor cells to migrate and invade. JR-AB2-011 also induces non-apoptotic cell death[2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2411853-34-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-122022. | |
| JS6 | JS6 is a Bcl3 inhibitor, and inhibits Bcl3-NF-kB1 binding. JS6 inhibits tumor cell growth in vitro and in vivo[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 950244-33-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-152177. | |
| JSH-150 | JSH-150 Inhibitor. Uses: Scientific use. Product Category: T8484. CAS No. 2247481-21-4. | |
| JSH-150 | JSH-150 is a highly selective and potent CDK9 inhibitor with an IC50 of 1 nM. Uses: Scientific research. Category: Signaling pathways. CAS No. 2247481-21-4. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-X0150. | |
| JSH-23 | JSH-23 is an inhibitor of NF-κB transcriptional activity, which inhibits LPS-stimulated nuclear factor (NF)-κB transcriptional activity in RAW 264.7 cells with an IC50 value of 7.1 μM, and interferes with LPS-induced NF-κB nuclear translocation without affecting IκB degradation. Group: Inhibitors. CAS No. 749886-87-1. Pack Sizes: 5mg. Product ID: S7351. Formula: C16H20N2. Smiles: CC1=CC(=C(C=C1)NCCCC2=CC=CC=C2)N. Storage Conditions: 2 years -80 in solvent. | United States; Europe |
| JSH-23 | JSH-23 is an NF-κB inhibitor which inhibits NF-κB transcriptional activity with an IC50 of 7.1 μM in lipopolysaccharide (LPS)-stimulated macrophages RAW 264.7. JSH-23 inhibits nuclear translocation of NF-κB p65 without affecting IκBα degradation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 749886-87-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13982. | |
| JS-K | JS-K is a NO donor that reacts with glutathione to generate NO at physiological pH. JS-K induces reactive oxygen species (ROS) to mediate apoptosis. JS-K induces autophagy. JS-K inhibits invasion. JS-K has a broad spectrum anti-proliferative activity in cancer cells. JS-K reduces tumor volume and causes necrosis of implanted tumors in mice[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 205432-12-8. Pack Sizes: 1 mg. Product ID: HY-126193. | |
| JT010 | JT010 is a covalent and site-selective TRPA1 agonist. JT010 can be used in myocardial infarction research[1][2][3][4][5][6]. Uses: Scientific research. Category: Signaling pathways. CAS No. 917562-33-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111132. | |
| JTC 801 | JTC 801. Group: Biochemicals. Grades: Purified. CAS No. 244218-51-7. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| JTC-801 | JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist, binding to ORL1 receptor with a Ki value of 8.2?nM. Uses: Scientific research. Category: Signaling pathways. CAS No. 244218-51-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13274. | |
| JTE 013 | JTE 013. Group: Biochemicals. Grades: Purified. CAS No. 547756-93-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| JTE-013 | JTE-013 is a potent and selective sphingosine-1-phosphate (S1P) receptor 2 (S1P2) antagonist (IC50=17.6 nM). Alternative Names: 1-(2,6-dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea; JTE-013; JTE 013; JTE013. Grades: >98%. CAS No. 383150-41-2. Molecular formula: C17H19Cl2N7O. Mole weight: 408.287. | |
| JTE-013 | JTE-013 is a potent and specific S1P2 (Sphingosine-1-Phosphate 2; EDG-5) antagonist. JTE-013 inhibits the specific binding of radiolabeled S1P to human and rat S1P2 with IC50s of 17 nM and 22 nM, respectively[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 383150-41-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100675. | |
| JTE-607 | JTE-607, a highly selective inflammatory cytokine synthesis inhibitor, protects from endotoxin shock in mice. JTE-607 inhibits inflammatory cytokine production, including TNF-α, IL-1β, IL-6, IL-8 and IL-10, from LPS-stimulated human PBMCs, with IC50s of 11, 5.9, 8.8, 7.3 and 9.1 nM, respectively[1]. Cleavage and Polyadenylation Specificity Factor 3 (CPSF3) is the target of JTE-607[2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 188791-09-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-110133. | |
| JTE 907 | JTE 907. Group: Biochemicals. Grades: Purified. CAS No. 282089-49-0. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| JTE-907 | JTE-907 is a selective and orally active cannabinoid CB2 receptor inverse agonist and exerts anti-inflammatory effects. JTE-907 upregulates IL-6, MCP-1, IL-1β, VEGF, ANGPTL4, and TRPV1 in mature adipocytes. JTE-907 downregulates CB1, MCP-1, and IL-1β in preadipocytes. JTE-907 inhibits ear swelling in mice. JTE-907 reverses the protective effects of CB2 agonists and Anandamide (HY-10863) against cytokine-evoked colonic mucosal damage. JTE-907 can be used for the research of allergic dermatitis, obesity, and colitis[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 282089-49-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-103325. | |
| JTP10-TATi | JTP10-TATi is a selective inhibitor of JNK2 peptide. Grades: >95%. CAS No. 1293399-25-3. Molecular formula: C118H212N48O26. Mole weight: 2719.24. | |
| JTT-501 | JTT-501. CAS No. 170861-63-9. Purity: 98%. Product ID: ACM170861639. Molecular formula: C22H20N2O5. Mole weight: 392.4. Alfa Chemistry - ISO 9001:32057 Certified. | |
| JTT 551 | JTT 551 is selective a protein tyrosine phosphatase 1B (PTP1B) inhibitor, with Kis of 0.22 μM and 9.3 μM for PTP1B and TCPTP (T-cell protein tyrosine phosphatase), respectively; JTT 551 can be used in the research of type 2 diabetes mellitus. Uses: Scientific research. Category: Signaling pathways. CAS No. 776309-04-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-19779. | |
| JTV 519 fumarate | JTV 519 fumarate. Group: Biochemicals. Grades: Purified. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| JTV-519 hemifumarate | JTV-519 hemifumarate (K201 hemifumarate) is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and a partial agonist of ryanodine receptors in striated muscle. Antiarrhythmic and cardioprotective properties[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: K201 hemifumarate. CAS No. 1435938-25-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15293B. | |
| Juglalin | Juglalin. Group: Biochemicals. CAS No. 99882-10-7. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Juglomycin A | Juglomycin A is originally isolated from Str. distatochromogenes var. juglonensis 190-2. It has a broad spectrum of antibacterial and mycobacterial effects, and has the effect of inhibiting ehrlician ascites cancer in mice and prolongating life with 1 mg/kg. Alternative Names: (-)-Juglomycin A; 1,4-Naphthalenedione,5-hydroxy-2-[(2R,3R)-tetrahydro-3-hydroxy-5-oxo-2-furanyl]-. CAS No. 38637-88-6. Molecular formula: C14H10O6. Mole weight: 274.22. | |
| Juglomycin B | Juglomycin B is originally isolated from Str. distatochromogenes var. juglonensis 190-2. It has a broad spectrum of antibacterial and mycobacterial effects, and has the effect of inhibiting ehrlician ascites cancer in mice and prolongating life with 1 mg/kg. Alternative Names: (+/-)-juglomycin A. CAS No. 38637-89-7. Molecular formula: C14H10O6. Mole weight: 274.22. | |
| juglone 3-monooxygenase | Also acts on 1,4-naphthoquinone, naphthazarin and 2-chloro-1,4-naphthoquinone, but not on other related compounds. Group: Enzymes. Synonyms: juglone hydroxylase; naphthoquinone hydroxylase; naphthoquinone-hydroxylase. Enzyme Commission Number: EC 1.14.99.27. CAS No. 98865-54-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1044; juglone 3-monooxygenase; EC 1.14.99.27; 98865-54-4; juglone hydroxylase; naphthoquinone hydroxylase; naphthoquinone-hydroxylase. Cat No: EXWM-1044. |  |
| Jujube | Jujube. |  |
| Jujube extract | Jujube extract. Applications: Jujube extract can be used in functional food, drinks, health care products and pharmaceuticals. Group: Others. Purity: 10:1 20:1. Appearance: Brown powder. Source: Ziziphus jujuba, commonly called jujube, sometimes jujuba, red date, Chinese date, Korean date, or Indian date is a species of Ziziphus in the buckthorn family (Rhamnaceae). It is used primarily as a shade tree that also bears fruit. Jujube extract; Fructus Jujubae. Cat No: EXTC-189. | |
| Jujube Seed Extract | Jujube seed extract is prepared from the natural plant of Semen Ziziphi Spinosae, which is traditional Chinese herb. Jujube seed extract contains jujuboside A, jujuboside B, betulinic acid, betulin and ect. Jujube seed extract was used to soothe the nerves, stop sweating, nourish the heart, benefit the liver, treat insomnia, tranquilize the mind. Group: Others. Mole weight: 1207.35. Jujube Seed Extract; Ziziphus Jujuba Mill. Cat No: EXTC-011. | |
| Jujube Seed Powder & Berry P.E. 20:1 | Jujube Seed Powder & Berry P.E. 20:1. |  CA, FL & NJ |
| Jujuboside A | Jujuboside A. Group: Biochemicals. Grades: Plant Grade. CAS No. 55466-04-1. Pack Sizes: 20mg. Molecular Formula: C58H94O26, Molecular Weight: 1207.35. US Biological Life Sciences. | Worldwide |
| Jujuboside A | Jujuboside A is a glycoside extracted from Semen Ziziphi Spinosae, a Chinese herbal medicine used to treat insomnia and anxiety. Uses: Scientific research. Category: Signaling pathways. CAS No. 55466-04-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0659. | |
| Jujuboside A | Jujuboside A may serve as a potential therapeutic agent for the treatment of Alzheimer?s disease. Uses: Therapeutic agent. Alternative Names: α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-β-D-glucopyranosyl-(1→6)-O-[β-D-xylopyranosyl-(1→2)]-β-D-glucopyranosyl-(1→3)]-; (3β,16β,23R)-16,23:16,30-Diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-β-D-glucopyranosyl-(1→6)-O-[β-D-xylopyranosyl-(1→2)]-β-D-glucopyranosyl-(1→3)]-α-L-arabinopyranoside. Grades: >98%. CAS No. 55466-04-1. Molecular formula: C58H94O26. Mole weight: 1207.35. | |
| Jujuboside B | Jujuboside B. Group: Biochemicals. Grades: Plant Grade. CAS No. 55466-05-2. Pack Sizes: 20mg. Molecular Formula: C52H84O21, Molecular Weight: 1045.21. US Biological Life Sciences. | Worldwide |
| Jujuboside B1 | Jujuboside B1. Group: Biochemicals. Grades: Plant Grade. CAS No. 68144-21-8. Pack Sizes: 10mg. Molecular Formula: C52H84O21, Molecular Weight: 1045.21. US Biological Life Sciences. | Worldwide |
| Jujuboside D | Botanical Source: Group: Biochemicals. Alternative Names: Jujuboside A1. Grades: Plant Grade. CAS No. 194851-84-8. Pack Sizes: 10mg, 20mg. US Biological Life Sciences. | Worldwide |
| Julimycin B2 | Julimycin B2 is originally isolated from Str. shiodaensis. It has anti-gram-positive bacteria and anti-virus activity and it has effects on ehrman ascites carcinoma in mice of 3.10-12.5 mg/kg. Alternative Names: Julimycin II; JULIMYCIN B2-CA; Julimycin B-II; (2,2'-Bianthracene)-8,8',9,9',10,10'(5H,5'H)-hexone, 6,6',7,7'-tetrahydro-1,1',6-beta,6'-beta-tetrahydroxy-5-beta,5'-beta-bis(1-hydroxyethyl)-6,6'-dimethyl-,5,5'-diacetate. Grades: >98%. CAS No. 18126-05-1. Molecular formula: C38H34O14. Mole weight: 714.67. | |
| Julolidine | Julolidine. Alternative Names: 2,3,6,7-Tetrahydro-1H,5H-benzo[ij]quinolizine. CAS No. 479-59-4. Molecular formula: C12H15N. Mole weight: 173.25. IUPAC Name: 1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8-triene. SMILES: C1CN2CCCc3cccc(C1)c23. InChI: 1S/C12H15N/c1-4-10-6-2-8-13-9-3-7-11(5-1)12(10)13/h1,4-5H,2-3,6-9H2,DZFWNZJKBJOGFQ-UHFFFAOYSA-N. | |
| jump Start 12V vehicle. | jump Start 12V vehicle. | |
| JUN68744 | JUN68744 is a useful peptide linker for synthesis of PSMA-617 (vipivotide tetraxetan), which is a ligand used to make 177Lu-PSMA-617, a radioactive molecule to fight cancer. PSMA-617 originally was developed at the German Cancer Research Center and the Heidelberg University Hospital. ABX held the exclusive license to bring the treatment, which targets prostate-specific membrane antigen (PSMA), through early clinical development. Alternative Names: JUN-68744; JUN 68744; PSMA-617-linker; PSMA 617-linker; PSMA617-linker; Vipivotide tetraxetan Linker; (((S)-5-((S)-2-((1r,4S)-4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid. CAS No. 1703768-74-4. Molecular formula: C33H45N5O9. Mole weight: 655.74. | |
| Juncuenin D | Juncuenin D, an all-natural compound, boasts of its potent anti-inflammatory and anticancer properties. Research studies exhibit its capability to suppress leukemia cells' growth via selective cell cycle arrest. Furthermore, it showcases its therapeutic potential in terms of inflammatory diseases by impeding pro-inflammatory cytokine production. Its revolutionary features highlight its significance as a potential therapeutic agent with immense curative measures. Alternative Names: Juncuenin D; 1161681-24-8; SCHEMBL23764926; HY-N8464; AKOS040762871; CS-0144572; F94140. Grades: 97.5%. CAS No. 1161681-24-8. Molecular formula: C18H18O3. Mole weight: 282.339. | |
Our database is helping our users find suppliers everyday.
